资讯|论坛|病例

搜索

首页 医学论坛 专业文章 医学进展 签约作者 病例中心 快问诊所 爱医培训 医学考试 在线题库 医学会议

您所在的位置:首页 > 医药资讯 > 华裔研究员巧妙构建新融合蛋白,解决粘膜疫苗传输问题(3)

华裔研究员巧妙构建新融合蛋白,解决粘膜疫苗传输问题(3)

2011-02-16 09:58 阅读:2215 来源:生物通 作者:大*勒 责任编辑:大弥勒
[导读] 来自美国马里兰大学的研究人员巧妙的构建了一种新型的融合蛋白,解决了粘膜疫苗的关键传输问题,并提出了一种可以简化粘膜疫苗的制备,分配及传递过程的新策略,这一研究成果公布在Nature Biotechnology杂志上。 文章的通讯作者是马里兰大学华裔学者朱小平副
 
  原文摘要:
 
  Efficient mucosal vaccination mediated by the neonatal Fc receptor
 
  Almost all infectious diseases are initiated at mucosal surfaces, yet intramuscular or subcutaneous vaccination usually provides only minimal protection at sites of infection owing to suboptimal activation of the mucosal immune system. The neonatal Fc receptor (FcRn) mediates the transport of IgG across polarized epithelial cells lining mucosal surfaces. We mimicked this process by fusing a model antigen, herpes simplex virus type-2 (HSV-2) glycoprotein gD, to an IgG Fc fragment. Intranasal immunization, together with the adjuvant CpG, completely protected wild-type, but not FcRn knockout, mice after intravaginal challenge with virulent HSV-2 186. This immunization strategy induced efficient mucosal and systemic antibody, B- and T-cell immune responses, with stable protection for at least 6 months after vaccination in most of the immunized animals. The FcRn-IgG transcellular transport pathway may provide a general delivery route for subunit vaccines against many mucosal pathogens.

分享到:
  版权声明:

  本站所注明来源为"爱爱医"的文章,版权归作者与本站共同所有,非经授权不得转载。

  本站所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,不希望被转载的媒体或个人可与我们

  联系zlzs@120.net,我们将立即进行删除处理

意见反馈 关于我们 隐私保护 版权声明 友情链接 联系我们

Copyright 2002-2025 Iiyi.Com All Rights Reserved